Total Payments
$2,050
2024 Payments
$604.30
Companies
13
Transactions
139
Payment Breakdown by Category
Food & Beverage$2,027 (98.9%)
Education$23.04 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,027 | 138 | 98.9% |
| Education | $23.04 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $659.53 | 52 | $0 (2024) |
| Novo Nordisk Inc | $381.62 | 23 | $0 (2024) |
| PFIZER INC. | $234.13 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $228.83 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $139.86 | 9 | $0 (2024) |
| Lilly USA, LLC | $134.15 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $91.16 | 5 | $0 (2024) |
| Lundbeck LLC | $59.86 | 4 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $42.87 | 3 | $0 (2022) |
| Organon Llc | $28.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $604.30 | 38 | ABBVIE INC. ($229.38) |
| 2023 | $589.17 | 43 | ABBVIE INC. ($180.35) |
| 2022 | $649.20 | 44 | ABBVIE INC. ($202.32) |
| 2021 | $207.69 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($78.58) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: ETONOGESTREL | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Obesity | ||||||
| 03/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
About Elizabeth Armstrong, FNP-C
Elizabeth Armstrong, FNP-C is a Family healthcare provider based in Low Moor, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1649565003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Armstrong, FNP-C has received a total of $2,050 in payments from pharmaceutical and medical device companies, with $604.30 received in 2024. These payments were reported across 139 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,027).
Ad
Practice Information
- Specialty Family
- Location Low Moor, VA
- Active Since 06/14/2011
- Last Updated 02/03/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649565003
Products in Payments
- VRAYLAR (Drug) $298.44
- REXULTI (Drug) $241.36
- QULIPTA (Drug) $205.38
- UBRELVY (Drug) $155.71
- Rybelsus (Drug) $144.15
- VYVANSE (Drug) $93.03
- NURTEC ODT (Drug) $82.19
- Wegovy (Drug) $77.75
- BREZTRI (Drug) $76.61
- MOUNJARO (Drug) $74.88
- Ozempic (Drug) $68.86
- PREVNAR 13 (Biological) $63.43
- Saxenda (Drug) $50.02
- ABILIFY MAINTENA (Drug) $47.33
- TRINTELLIX (Drug) $46.83
- TRULICITY (Drug) $44.17
- NEXPLANON (Drug) $28.09
- ELIQUIS (Drug) $26.83
- PREMARIN (Drug) $26.07
- MYFEMBREE (Drug) $23.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.